Leading testing company Himax Technologies (3587-TW) announced today (8th) its June revenue reached NT$558 million, representing a 2.56% increase month-on-month and an 11.01% increase year-on-year, marking the fourth consecutive month of record-high revenue. Second-quarter revenue totaled NT$1.644 billion, setting a new quarterly record, while cumulative revenue for the first six months reached NT$3.068 billion, up 17.47% year-on-year. This growth is attributed to surging outsourced demand for high-end materials analysis (MA) and failure analysis (FA), driven by global investment in advanced AI chips and accelerated development of cutting-edge semiconductor processes.

At the June GTC conference in Taipei, NVIDIA (NVDA-US) announced that the Spectrum-X CPO switch, co-developed with TSMC (2330-TW, TSM-US), has begun shipping to select partners and is expected to scale up mass production in the second half of the year. This marks a pivotal shift in AI infrastructure from pure computational power competition toward high-speed transmission and optoelectronic integration. While the new product offers up to five times greater power efficiency compared to traditional pluggable optical transceivers, the complexity of its heterogeneous packaging interface has increased exponentially.

During the development of silicon photonics and CPO technologies, novel defects arising from complex heterogeneous stacking have driven strong, outsourced demand across the global supply chain for optoelectronic interface materials analysis and high-speed signal failure diagnostics. As a third-party independent testing leader, Himax has secured a strategic position in the silicon photonics supply chain, with its testing and analysis services achieving over 50% penetration. Its service scope comprehensively covers key segments including PIC design, foundry, laser sources, and optical modules.

Silicon photonics and optoelectronic integrated chips require extremely precise manufacturing processes, particularly in the generation of laser components, which demand highly accurate multi-element doping control and epitaxial engineering. New-generation silicon photonics chips may develop microscopic defects at heterogeneous wafer bonding interfaces, waveguide microstructures, and material junctions, exceeding the resolution limits of traditional physical analysis techniques at the sub-nanometer scale.

Himax’s installed high-sensitivity Secondary Ion Mass Spectrometry (SIMS) system enables doping depth and trace impurity analysis unattainable with conventional methods. With exceptional sensitivity, it precisely observes interface roughness, trace impurity distribution, and doping concentration profiles within materials, making it the preferred solution for major manufacturers to ensure high optoelectronic conversion efficiency.

Under the CPO heterogeneous integration packaging architecture, performance degradation in chips—whether during product development, mass production, or after reliability testing—significantly increases the difficulty of failure analysis (FA) and defect localization. To meet the rising FA demands from CPO development, Himax installed its first dedicated failure localization platform for high-end optoelectronic products in June. Leveraging its extensive optoelectronic integration testing database and advanced FA equipment, the company can rapidly pinpoint signal attenuation and coupling failure nodes, helping global clients drastically reduce trial-and-error costs and shorten time-to-market.

As silicon photonics and CPO technologies enter intensive R&D and verification phases, Himax is well-positioned to capture more high-customization, high-value testing projects. Its advanced MA capabilities and proven FA expertise in optoelectronic coupling are expected to become key drivers of sustained long-term operational growth.

FACT BOX

  • Source: PR Times
  • Category: News